Oncology
0 drugs are in development for Urinary Bladder Neoplasms.
- Companies
- 0
- Clinical trials
- 15
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Urinary Bladder Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Urinary Bladder Neoplasms context
Oncology·MeSH: Urinary Bladder Neoplasms (D001749)
Also known as: Bladder Neoplasm, Bladder Tumor, Neoplasm, Urinary Bladder, Neoplasms, Bladder, Tumors, Bladder
Narrower concepts tracked separately: Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
Frequently asked questions
How many clinical trials target Urinary Bladder Neoplasms?
There are 15 clinical trials targeting Urinary Bladder Neoplasms tracked by BioSniper.
What is the prevalence of Urinary Bladder Neoplasms?
The estimated prevalence of Urinary Bladder Neoplasms is approximately 61.0 per 100,000 population.